newsfilter
← Latest News
FDA Approved Drugs·

Approval of Xeljanz, Nda #213082 (Labeling)

Approval Date: 09/16/2026; Drug Name: Xeljanz, Nda #213082; Active Ingredients: TOFACITINIB CITRATE; Company: Pfizer; Submission Status: Approval; Submission Classification: Labeling; Application Number: 213082

Company
PFIZER
Keywords
PFIZER